New clinical study confirms Neuravena's efficacy on cognitive performance

Frutarom to highlight cognitive health breakthrough at SupplySide West

A successful clinical study confirms previously demonstrated benefits of Neuravena on acute improvement of cognitive function, showing efficacy for an 800mg dose.

Neuravena is produced and marketed by Frutarom BU Health and will be featured at SupplySide West (5-9 October) on booth 1469.

The maintenance of cognitive function, even in stressful situations, has become essential in our society, based on performance and changing social trends.

The need to think better or stay more concentrated and focused — be it at work, during an exam or at home — is becoming increasingly important. However, it is not always easy to manage the multiple challenges of daily life. A growing number of people perceive a cumulative level of stress that, in the long run, can lead to mental and physical health issues.

The new, placebo-controlled, double-blind, randomised crossover study investigated the effects of 800mg of Neuravena on cognitive performance, using the Computerised Mental Performance Assessment System (COMPASS) — a battery of tests selected to allow assessments across the major cognitive domains, including global functioning (speed, accuracy), attention, working and episodic memory and executive function.

'We are committed to science and technology, and focus on proprietary studies that support the efficacy and safety of our ingredients,' says Nicolas Meyrial, Vice President of Sales and Business Development for Frutarom BU Health North America. 'This new clinical study — the fifth on Neuravena — confirms that ongoing commitment.'

The study shows that a single 800mg dose of Neuravena provides significant benefits related to cognitive function. The results of the study indicate a significant improvement of the ‘Speed of Performance’ measure across all the timed tasks within the cognitive tests battery, indicating general benefit to brain function.

These results also indicate an improved executive function, via faster performance in the Peg and Ball test; improved working memory performance (via second run of Corsi Blocks task); and improved episodic memory through fewer incorrect words generated on the 'Delayed Word Recall' task.

Neuravena is an extract of a proprietary variety of green oat (Avena sativa). Frutarom's EFLA HyperPure patented technology, used to produce Neurvana, ensures good solubility, stability, purity and the removal of contaminants. Neuravena is a natural, safe and effective ingredient suitable for food multiple supplements and food and beverage formats, such as energy drinks, cereals bars, cookies and dairy products.

Featured Companies

Frutarom Health (more information, website)